期刊文献+

2018美国眼科学会干眼指南解读 被引量:22

Interpretation of 2018 Dry Eye Syndrome Preferred Practice Pattern (DEsPPP)
下载PDF
导出
摘要 美国眼科学会(American Academy of Ophthalmology,AAO)近期出台的2018年干眼(dry eye disease,DED)临床指南,对DED的定义、发病人群、分类、检测方法与治疗等做了详细介绍。本文将对该指南进行全面解读。 American Academy of Ophthalmology(AAO) recently issued 2018 Dry Eye Syndrome Preferred Practice Pattern(DEsPPP),which gives a detailed introduction to the definition,patient population,classification,detection methods and treatment of dry eye.We will make a comprehensive interpretation of this guideline in this article.
作者 邵毅 石文卿 SHAO Yi;SHI Wen-Qing(Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China)
出处 《眼科新进展》 CAS 北大核心 2019年第12期1101-1104,1110,共5页 Recent Advances in Ophthalmology
基金 国家自然科学基金资助(编号:81660158,81460092,81400372) 江西省自然科学基金重大项目(编号:20161ACB2-1017) 江西省青年科学基金(编号:20151B-AB215016,20161BAB215198) 江西省重点研发项目(编号:20151BBG70223,20181B-BG70004) 江西省教育厅重点项目(编号:GJJ160020) 江西省学位与研究生教育教学改革研究项目(编号:JXYJG-2018-013) 江西省基层卫生适宜技术“星火推广计划”项目(编号:20188003) 江西省卫计委科技计划面上项目(编号:20175116) 江西省卫计委中医药科技计划项目(编号:2018A060)~~
关键词 干眼 诊断 治疗 指南 dry eye diagnosis treatment guideline
  • 相关文献

参考文献11

二级参考文献63

  • 1胡建民,林玲,高莹莹,洪玉,庄铭忠.类风湿性关节炎患者眼表损害临床分析[J].临床眼科杂志,2004,12(3):212-215. 被引量:2
  • 2刘祖国,杨文照.干眼症的发病机制[J].眼科,2005,14(5):342-345. 被引量:141
  • 3李学民,张君,王薇.泪道栓塞术治疗干眼症的临床效果[J].中华眼科杂志,2005,41(12):1098-1102. 被引量:41
  • 4刘祖国.干眼的治疗[J].中华眼科杂志,2006,42(1):71-74. 被引量:98
  • 5严厉,顾宝文,司马晶,王晖,邓惠芳.眼科门诊患者中干眼症的流行病学调查[J].解剖与临床,2006,11(3):200-201. 被引量:50
  • 6Ayaki M, Iwasawa A, Inoue Y. Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells. Clin Ophthalmol, 2010, 4: 1217-1222.
  • 7Manni G, Centofanti M, Oddone F, et al. Interleukin-lbeta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers. Am J Ophthalmol, 2005, 139(1): 72-77.
  • 8Rossi GC, Pasinetti GM, Scudeller L, et al. Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination. Expert Opin Pharmacother, 2010, 11 (4): 499-504.
  • 9Lewis RA, Katz GJ, Weiss MJ, et al. Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy. J Glaucoma, 2007, 16(1): 98-103.
  • 10Hamacher T, Airaksinen J, Saarela V, et al. Efficacy and safety levels of preserved and preservative-free tattuprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis. Acta Ophthalmol Suppl (Oxf), 2008, 242: 14-19.

共引文献133

同被引文献220

引证文献22

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部